Intense and recurrent déjà vu experiences related to amantadine and phenylpropanolamine in a healthy male

  title={Intense and recurrent d{\'e}j{\`a} vu experiences related to amantadine and phenylpropanolamine in a healthy male},
  author={T. J. Taiminen and Satu K. J{\"a}{\"a}skel{\"a}inen},
  journal={Journal of Clinical Neuroscience},
We report a case of a 39-year-old caucasian healthy male physician who developed intense and recurrent déjà vu experiences within 24h of initiating concomitant amantadine-phenylpropanolamine treatment against influenza. Déjà vu experiences terminated on discontinuation of medication. Findings in temporal epilepsy suggest that mesial temporal structures, including hippocampus, are related to paramnesic symptoms. On the other hand, previous case reports have confirmed that both amantadine and… 

Recurring déjà vu associated with 5-hydroxytryptophan

An iatrogenic case with implications for the neuropharmacological basis of déjà vu, in which a 42-year-old woman received 5-hydroxytryptophan, in combination with carbidopa, as treatment for palatal tremor, on two occasions, separated by 1 week.

Déjà Vécu: When Groundhog Day Gets Real

An 84-year-old woman with idiopathic, partial deja vecu is described, where her symptoms were limited to people and events and the patient and her family were offered psychoeducation, which led to acceptance and improved coping.

A review of the déjà vu experience.

Systematic research is needed on the prevalence and etiology of this culturally familiar cognitive experience, and several laboratory models may help clarify this illusion of recognition.

Neuroimaging and cognitive changes during déjà vu

The persistence of erroneous familiarity 3 Acknowledgements

We report the case of a 39 year-old, temporal lobe epileptic male, MH. Prior to complex partial seizure, experienced up to three times a day, MH often experiences an aura experienced as a persistent

Temporal Lobe Epilepsy (TLE) , “déjà vu” phenomenon and religious experiences

A lot of controversies appear regarding temporal lobe epilepsy to bridge the gap between religion and neuroscience. TLE was described in literature in 1869 by Russian writer Dostoievski (who suffered

Reduplicative Paramnesia: A Review

There does appear to be a consensus that RP may have a neurologic rather than psychiatric cause and that right and bifrontal lesions as well as the cognitive dissonance associated with memory, visuospatial and impaired conceptual integration are common factors in RP presentation.

A Review of the DejaVu Experience

For more than a century, the dejavu experience has been examined through retrospective surveys, prospective surveys, and case studies. About 60% of the population has experienced dejavu, and its



Phenylpropanolamine-induced psychosis. Potential predisposing factors.

Effect of Amantadine on Sexual Dysfunction in Neuroleptic‐Treated Male Schizophrenic Patients

Amantadine may be effective for improving sexual function in male schizophrenic patients receiving neuroleptic medication, according to patients' scores in three out of four areas of sexual function.

Possible use of amantadine in depression.

Only a limited body of evidence is available, and further studies are needed to investigate the efficacy of amantadine as well as its modes of action in depression, but an overview of the current data is presented.

Mental side effects of amantadine therapy: its spectrum and characteristics in a normal population.

The author does not feel the findings warrant discontinuing the prophylactic usage of amantadine but do highlight the need for physician and patient education about its side effects.

Déjà Vu Experiences and Reduplicative Paramnesia

A schizophrenic patient with different forms of experiences of inappropriate familiarity with traumatic experiences as aetiological factors in déjà vu experiences and reduplicative paramnesia is described.

Clinical use of amantadine in brain injury rehabilitation.

It is suggested amantadine may play a role in neurobehavioural recovery of brain injury, and the need for more in-depth study is demonstrated.

Episodic Psychic Symptoms in the General Population

It is proposed that some subclinical dysfunctions can be associated with the appearance of episodic psychic phenomena in otherwise normal subjects.

Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine

Present results are consistent with stimulation of DDC activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine, and suggest that this response is an important mechanism underlying the anti‐parkinsonian properties of amanadine.

Development, Reliability, and Validity of a Dissociation Scale

  • E. Bernstein
  • Psychology, Medicine
    The Journal of nervous and mental disease
  • 1986
The Dissociative Experiences Scale (DES) has been developed to offer a means of reliably measuring dissociation in normal and clinical populations and was able to distinguish between subjects with a dissociative disorder (multiple personality) and all other subjects.